Jian Zhang - Concepedia

Author

Jian Zhang

Fudan University Shanghai Cancer Center ORCID

Also Known As

J. Zhang, Jian Zhang

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Fudan University Shanghai Cancer Center Shanghai Medical College of Fudan University Hunan Cancer Hospital Huazhong University of Science and Technology Harbin Medical University

About

Jian Zhang is an author at Fudan University Shanghai Cancer Center specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	167
2	Cell Biology	2	2	51
3	Biochemistry	1	1	29
4	Gastroenterology	1	1	13
5	Immunology	1	1	22

Jian Zhang

Publications

659

Citations

H-Index

Page 1

	Year	Citations
Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer Bi-Yun Wang, Jian Zhang, Jia-Lei Wang, Journal of Experimental & Clinical Cancer Research	2015	177
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer Jia Jin, Yu Gao, Jian Zhang, BMC Cancer	2018	114
A Phase I study of safety and pharmacokinetics of fruquintinib, a novel selective inhibitor of vascular endothelial growth factor receptor-1, -2, and -3 tyrosine kinases in Chinese patients with advanced solid tumors Junning Cao, Jian Zhang, Wei Peng, Cancer Chemotherapy and Pharmacology AngiogenesisGliomaMedicinePharmacologyAdvanced Solid Tumors	2016	70
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study Jie Xie, Jun Cao, Jingfen Wang, Breast Cancer Research and Treatment Breast OncologyBreast Cancer PatientsMedicineClinical TrialsMultiple Cycles	2017	33
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial Herui Yao, Min Yan, Zhongsheng Tong, Journal of Clinical Oncology	2024	32
Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway Jie Xie, Zhonghua Tao, Jiang Zhao, Biochemical and Biophysical Research Communications BiochemistryMitochondrial FunctionBreast Cancer CellMedicineApoptosis	2016	29
Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: A SEER population-based study Shuchen Lin, Chang Liu, Zhonghua Tao, The Breast	2019	24
Dalpiciclib Combined With Pyrotinib and Letrozole in Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer (LORDSHIPS): A Phase Ib Study Jian Zhang, Yanchun Meng, Biyun Wang, Frontiers in Oncology	2022	23
The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells Lei-Ping Wang, Jun Cao, Jian Zhang, Medical Oncology Tumor BiologySignal TransductionSignaling PathwayCell RegulationCcl2-induced Phosphorylation	2015	22
PEGylated zinc oxide nanoparticles induce apoptosis in pancreatic cancer cells through reactive oxygen species Yiqun Du, Jian Zhang, Shiyan Yan, IET Nanobiotechnology	2019	22

Page 1